NCT06863974View on ClinicalTrials.gov

High-throughput Omic Technology for Identification of Biomarkers of Relapsing Acute Disseminated Encephalomyelitis in Immune Cell Network

NANot yet recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 1, 2026

Primary Completion Date

April 1, 2027

Study Completion Date

February 1, 2030

Conditions
Acute Disseminated EncephalomyelitisEncephalitis Autoimmune
Interventions
OTHER

Blood test

Drawing blood to realize biomarkers of disease course of MOGAD-ADEM and pathophysiology of ADEM (and MOGAD) : cellular and molecular signatures, inflammatory signaling.

Trial Locations (6)

29200

Univesity Hostipal of Brest, Brest

35000

Univesity Hostipal of Rennes, Rennes

37000

Univesity Hostipal of Tours, Tours

44093

Univesity Hostipal of Nantes, Nantes

72037

Univesity Hostipal of Le Mans, Le Mans

94270

Univesity Hostipal of APHP, Le Kremlin-Bicêtre

All Listed Sponsors
lead

University Hospital, Angers

OTHER_GOV

NCT06863974 - High-throughput Omic Technology for Identification of Biomarkers of Relapsing Acute Disseminated Encephalomyelitis in Immune Cell Network | Biotech Hunter | Biotech Hunter